Malignant mesothelioma in situ: diagnostic and clinical considerations

Germline BAP1 mutations predispose to malignant mesothelioma

Joseph R. Testa, Mitchell Cheung, Jianming Pei et al. · Nature Genetics · 2011 · 1.1K citations · Full text

Medicine, Germline Bap1 Mutations, Pathology +1

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

Eric G. Butchart, T Ashcroft, William Barnsley et al. · Thorax · 1976 · 527 citations · Full text

Neuro-oncology, Surgical Oncology, Medicine +11

High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma

Masaki Nasu, Mitsuru Emi, Sandra Pastorino et al. · Journal of Thoracic Oncology · 2015 · 322 citations · Full text

Tumoral Pathology, Somatic Bap1 Alterations, Pathology +2

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

Peter B. Illei, Valerie W. Rusch, Maureen F. Zakowski et al. · PubMed · 2003 · 313 citations

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations

Marta Cigognetti, Silvia Lonardi, Simona Fisogni et al. · Modern Pathology · 2015 · 299 citations · Full text

Malignant Disease, Medicine, Reactive Mesothelial Proliferations +6